《大行報告》大摩相信潤啤(00291.HK)股價60日內將升
摩根士丹利發表技術研究報告,華潤啤酒(00291.HK)的股價將在60日內上漲,發生此概率料介乎70%至80%,評級「增持」,目標價67元。
該行表示,潤啤近期股價回調後,該股短期估值更具吸引力。喜力(Heineken)應可繼續通過進一步的渠道滲透來實現良好的增長,並透過有效的渠道投資在高級領域佔據市場份額。該行提到,喜力錄得強勁的增長,2023年第二季是啤酒的旺季,在去年的低基數下,預計渠道復甦將受惠於銷量增長,以及由有利產品組合驅動的高端化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.